BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15118095)

  • 1. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
    Paterson JM; Morton NM; Fievet C; Kenyon CJ; Holmes MC; Staels B; Seckl JR; Mullins JJ
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7088-93. PubMed ID: 15118095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
    Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
    PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.
    Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE
    Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.
    Heitaku S; Sasase T; Sotani T; Maki M; Kawai T; Morinaga H; Nishiu J
    J Pharmacol Sci; 2024 Apr; 154(4):246-255. PubMed ID: 38485342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral fat sympathectomy ameliorates systemic and local stress response related to chronic sleep restriction.
    Azuara-Alvarez LE; Díaz-Muñoz M; Báez Ruiz A; Saderi N; Ramírez-Plascencia OD; Cárdenas-Romero S; Flores-Sandoval O; Salgado-Delgado R
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2381-2392. PubMed ID: 38143435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hippocampal long-term potentiation and spatial learning in aged 11beta-hydroxysteroid dehydrogenase type 1 knock-out mice.
    Yau JL; McNair KM; Noble J; Brownstein D; Hibberd C; Morton N; Mullins JJ; Morris RG; Cobb S; Seckl JR
    J Neurosci; 2007 Sep; 27(39):10487-96. PubMed ID: 17898220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Adrenergic Stimulation-Induced PVAT Dysfunction in Male Sex: A Role for 11β-Hydroxysteroid Dehydrogenase-1.
    Victorio JA; Barssotti L; Aprahamian T; Costa RG; Mousovich-Neto F; Oliveira HCF; Mori M; Rossoni LV; Davel AP
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38712392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis.
    Kong S; Ruan J; Zhang K; Hu B; Cheng Y; Zhang Y; Yang S; Li K
    PeerJ; 2018; 6():e4542. PubMed ID: 29682407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model.
    Yuan X; An G
    J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38652112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-Induced Fatty Liver Disease.
    Rahimi L; Rajpal A; Ismail-Beigi F
    Diabetes Metab Syndr Obes; 2020; 13():1133-1145. PubMed ID: 32368109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.
    Kotelevtsev Y; Holmes MC; Burchell A; Houston PM; Schmoll D; Jamieson P; Best R; Brown R; Edwards CR; Seckl JR; Mullins JJ
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14924-9. PubMed ID: 9405715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
    Morgan SA; McCabe EL; Gathercole LL; Hassan-Smith ZK; Larner DP; Bujalska IJ; Stewart PM; Tomlinson JW; Lavery GG
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2482-91. PubMed ID: 24889609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
    Chapman K; Holmes M; Seckl J
    Physiol Rev; 2013 Jul; 93(3):1139-206. PubMed ID: 23899562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Polyzos SA; Targher G
    Curr Obes Rep; 2024 Mar; ():. PubMed ID: 38459229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Environmental Enrichments on Welfare and Hepatic Metabolic Regulation of Broiler Chickens.
    Kang SW; Christensen KD; Jr MTK; Orlowski SK
    Animals (Basel); 2024 Feb; 14(4):. PubMed ID: 38396525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G6PC1 and G6PC2 influence G6P flux but not HSD11B1 activity.
    Hawes EM; Boortz KA; Oeser JK; O'Rourke ML; O'Brien RM
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37855366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids contribute to metabolic and liver impairments induced by lactation overnutrition in male adult rats.
    de Souza CF; Stopa LRS; Martins AB; Wunderlich ALM; Lopes GM; de Fatima Silva F; Komino ACM; Zaia DAM; Zaia CTBV; Lima FB; Uchoa ET
    Front Physiol; 2023; 14():1161582. PubMed ID: 37234421
    [No Abstract]   [Full Text] [Related]  

  • 19. High salt intake activates the hypothalamic-pituitary-adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice.
    Costello HM; Krilis G; Grenier C; Severs D; Czopek A; Ivy JR; Nixon M; Holmes MC; Livingstone DEW; Hoorn EJ; Dhaun N; Bailey MA
    Cardiovasc Res; 2023 Jul; 119(8):1740-1750. PubMed ID: 36368681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice.
    Akalestou E; Lopez-Noriega L; Christakis I; Hu M; Miras AD; Leclerc I; Rutter GA
    Front Endocrinol (Lausanne); 2022; 13():1020576. PubMed ID: 36246869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.